PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KO vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between KO and NVS is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

KO vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Coca-Cola Company (KO) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%SeptemberOctoberNovemberDecember2025February
2.49%
-8.87%
KO
NVS

Key characteristics

Sharpe Ratio

KO:

1.49

NVS:

0.65

Sortino Ratio

KO:

2.26

NVS:

1.01

Omega Ratio

KO:

1.27

NVS:

1.13

Calmar Ratio

KO:

1.39

NVS:

0.56

Martin Ratio

KO:

3.09

NVS:

1.25

Ulcer Index

KO:

6.97%

NVS:

8.97%

Daily Std Dev

KO:

14.33%

NVS:

17.05%

Max Drawdown

KO:

-68.21%

NVS:

-41.72%

Current Drawdown

KO:

-2.68%

NVS:

-11.23%

Fundamentals

Market Cap

KO:

$301.44B

NVS:

$211.16B

EPS

KO:

$2.46

NVS:

$5.87

PE Ratio

KO:

28.48

NVS:

18.21

PEG Ratio

KO:

2.93

NVS:

3.19

Total Revenue (TTM)

KO:

$47.06B

NVS:

$51.07B

Gross Profit (TTM)

KO:

$28.74B

NVS:

$38.17B

EBITDA (TTM)

KO:

$15.01B

NVS:

$20.75B

Returns By Period

In the year-to-date period, KO achieves a 12.50% return, which is significantly higher than NVS's 10.28% return. Over the past 10 years, KO has outperformed NVS with an annualized return of 8.71%, while NVS has yielded a comparatively lower 6.27% annualized return.


KO

YTD

12.50%

1M

12.21%

6M

2.49%

1Y

17.86%

5Y*

6.36%

10Y*

8.71%

NVS

YTD

10.28%

1M

7.60%

6M

-8.87%

1Y

8.63%

5Y*

7.58%

10Y*

6.27%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

KO vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KO
The Risk-Adjusted Performance Rank of KO is 8282
Overall Rank
The Sharpe Ratio Rank of KO is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of KO is 8484
Sortino Ratio Rank
The Omega Ratio Rank of KO is 8080
Omega Ratio Rank
The Calmar Ratio Rank of KO is 8585
Calmar Ratio Rank
The Martin Ratio Rank of KO is 7373
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 6363
Overall Rank
The Sharpe Ratio Rank of NVS is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 5959
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 5959
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 6969
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

KO vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Coca-Cola Company (KO) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for KO, currently valued at 1.49, compared to the broader market-2.000.002.001.490.65
The chart of Sortino ratio for KO, currently valued at 2.26, compared to the broader market-4.00-2.000.002.004.006.002.261.01
The chart of Omega ratio for KO, currently valued at 1.27, compared to the broader market0.501.001.502.001.271.13
The chart of Calmar ratio for KO, currently valued at 1.39, compared to the broader market0.002.004.006.001.390.56
The chart of Martin ratio for KO, currently valued at 3.09, compared to the broader market-10.000.0010.0020.0030.003.091.25
KO
NVS

The current KO Sharpe Ratio is 1.49, which is higher than the NVS Sharpe Ratio of 0.65. The chart below compares the historical Sharpe Ratios of KO and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.49
0.65
KO
NVS

Dividends

KO vs. NVS - Dividend Comparison

KO's dividend yield for the trailing twelve months is around 2.77%, less than NVS's 3.52% yield.


TTM20242023202220212020201920182017201620152014
KO
The Coca-Cola Company
2.77%3.12%3.12%2.77%2.84%2.99%2.89%3.29%3.23%3.38%3.07%2.89%
NVS
Novartis AG
3.52%3.88%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

KO vs. NVS - Drawdown Comparison

The maximum KO drawdown since its inception was -68.21%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for KO and NVS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-2.68%
-11.23%
KO
NVS

Volatility

KO vs. NVS - Volatility Comparison

The current volatility for The Coca-Cola Company (KO) is 7.08%, while Novartis AG (NVS) has a volatility of 7.49%. This indicates that KO experiences smaller price fluctuations and is considered to be less risky than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%SeptemberOctoberNovemberDecember2025February
7.08%
7.49%
KO
NVS

Financials

KO vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between The Coca-Cola Company and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab